IBC, Protedyne, Galapagos | GenomeWeb

IBC, Protedyne, Galapagos

Premium

IBC to Hold Inaugural High-Content Analysis Conference

IBC Life Sciences will hold its first annual conference on high-content analysis Nov. 17-18 in Washington, DC, the company said last week.

The conference will feature discussions and presentations about "how to effectively utilize high-content cellular analysis for screening and go/no-go decision making," IBC said, including case studies from Eli Lilly and Wyeth, and presentations from James Inglese of the NIH Chemical Genomics Center and Ralph Garippa of Hoffman-La Roche.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.